Platinum-Resistant Fallopian Tube Carcinoma

general

Fallopian tube carcinoma that progresses between one and six months of completing platinum therapy.

64

Centers

106

Active Trials

$9.2B

Cancer Funding

Specific Cancer Types(1)

Top Centers for Platinum-Resistant Fallopian Tube Carcinoma(64)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
172.7
2
NCI Comprehensive
High-Volume Research Center
72.7
3
NCI Comprehensive
Active Research Program
60.3
4
NCI Comprehensive
Active Research Program
60.3
5
NCI Comprehensive
Active Research Program
60.3
6
NCI Comprehensive
Active Research Program
60.3
7
NCI Comprehensive
Active Research Program
60.3
8
NCI Comprehensive
Active Research Program
60.3
9
NCI Comprehensive
Active Research Program
60.3
10
NCI Comprehensive
Active Research Program
60.3
11
NCI Clinical
Active Research Program
60.3
12
NCI Comprehensive
Active Research Program
60.3
13
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
60.3
14
Active Research Program
60.3
15
Active Research Program
60.3
16
Active Research Program
60.3
17
NCI Comprehensive
39.3
18
NCI Comprehensive
39.3
19
NCI Comprehensive
39.3
20
NCI Comprehensive
39.3
21
NCI Comprehensive
39.3
22
NCI Comprehensive
39.3
2339.3
24
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
39.3
2539.3
2639.3
2739.3
2839.3
29
BC CancerVancouver, BC
39.3
30
NCI Comprehensive
31
32
33
NCI Comprehensive
34
NCI Comprehensive
35
36
37
NCI Comprehensive
38
39
40
NCI Comprehensive
41
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
42
NCI Comprehensive
43
NCI Comprehensive
44
45
46
47
NCI Comprehensive
48
49
50
NCI Comprehensive
51
52
NCI Comprehensive
53
54
55
56
57
NCI Basic_laboratory
58
59
60
61
62
63
64

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →